The weekly litigation news digest is live. Subscribe now

Biomarin competitive analysis

Explore patent oppositions filed by Biomarin against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 8, 2026
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by Biomarin

A Concentrated Krill Protein Hydrolysate FractionRIMFROSTAug 29, 2023
Method For Processing Crustaceans To Produce Low Fluoride/Low Trimethyl Amine Products ThereofRIMFROSTAug 24, 2022
Method For Processing Crustaceans To Produce Low Fluoride/Low Trimethyl Amine Products ThereofOLYMPIC SEAFOODOct 24, 2018

Explore Biomarin's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jan 8, 2026
Patent NumberPublication DateTitleTotal Oppositions

Get instant alerts of patent oppositions faced by Biomarin

Mar 13, 2024Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal Dysplasia3
May 11, 2022Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5
Apr 6, 2022Means And Methods For Counteracting Muscle Disorders2
Jan 26, 2022Treatment Of Phenylketonuria With Bh43
Dec 15, 2021Rna Modulating Oligonucleotides With Improved Characteristics For The Treatment Of Duchenne And Becker Muscular Dystrophy2
Dec 1, 2021Variants Of C-Type Natriuretic Peptide2
Dec 16, 2020Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5

Latest PTAB cases involving Biomarin

Discover the latest PTAB cases involving Biomarin, highlighting their recent legal challenges and patent disputes.

Last updated on: Jan 8, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Biomarin

PGR2026-00013Nov 24, 2025ASCENDIS PHARMABIOMARIN PHARMACEUTICALPending
IPR2013-00534Aug 28, 2013BIOMARIN PHARMACEUTICALGENZYME THERAPEUTIC PRODUCTS PARTNERSHIPFinal Written Decision
IPR2013-00535Aug 28, 2013BIOMARIN PHARMACEUTICALDUKE UNIVERSITYFinal Written Decision
IPR2013-00537Aug 28, 2013BIOMARIN PHARMACEUTICALGENZYME THERAPEUTIC PRODUCTS PARTNERSHIPFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Biomarin with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 8, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AKER BIOMARINE ANTARCTIC14 - 12
OLYMPIC SEAFOOD - 1 - -
RIMFROST4412 -